The founding rector of our university and head of Department of Neurosurgery Prof. Dr. Necmettin Pamir and the Dean of School of Medicine Prof. Dr. Yasemin Alanay ranked among the successful Turkish research working at respected research institution in the research “100 Turkish Scientists who Influenced Medical Sciences” by Turkishtime magazine.
Prof. Dr. Necmettin Pamir graduted from Istanbul University Cerrahpaşa School of Medicine in 1976. He completed his residency at Hacettepe University, specializing in neurosurgery. He did clinical neurosurgery research at Sweden-Karolinska Institute and Switzerland-Zurich University between 1984 and 1985. In 1991, he was appointed to Marmara University Neurological Sciences Institute as the director. In 1992, he contributed to clinical neurosurgery research at Pittsburg, Virginia and George Washington University in the United States.
Prof. Pamir became the head of Department of Neurosurgery at Marmara University and remained in that position until 2008. He was also the director of Marmara University Institute of Neurological Sciences and the chief physician of Marmara University Hospital. He became the member of Marmara University Neurological Sciences Foundation, Marmara University Circulation Capital Board of Directors and Marmara University Circulation Capital Procurement Department. Prof. Pamir has been the head of Acıbadem University Department of Neurosurgery since 2008. Prof. Pamir served as the founding rector of Acıbadem University between 2008-2012.
Pamir is the first Turkish neurosurgeon to be selected to the World Academy Neurologial Surgery, top institution for neurosurgery in the world. He is a member of several neurology related foundations and associations. He is continuing his work at Acıbadem University.
Prof. Dr. Yasemin Alanay is specialized in pediatrics and pediatric genetic diseases. She graduted from Hacettepe University School of Medicine with English teaching medium, and after grauated she did an internship at Marmara University School of Medicine Department of Pediatrics. She finished her residency at Hacettepe University School of Medicine Department of Pediatrics between 1997-2001. She served as the chief pediatrics intern between 2001-2002. At the end of 2002, she started working at Pediatrics Genetics Unit as a resident, where she conducted her residency thesis. Between 2006-2007, she received training on “Skeletal Dysplasia”at Los Angeles Cedars Sinai Medical Center for 1 year.
In 2010, she was awarded Hacettepe University Scientific Encouragement Award. In 2011, pediatric genetics was recognized as a subspecialty of perdiatrics. Dr. Alanay was among the first physicians who received a subspecialty diploma. She received her professor title in 2013. Dr. Alanay contributed many multi-institutional projects in Europe and the United States, and elucidation of genetic reasons underlying many diseaes. Specifically, she is the first author of research projects on identifying genes of facial development and recessively inherited osteogenesis imperfecta. She identified two new genes in this area.
She is among the founders of Pediatric Genetic Diseases Association, and a member of International Skeletal Dysplasia Society, European Society of Human Genetics, Turkish National Pediatric Society, American Society of Human Genetics (ASHG), Turkish Pediatric Association. She has numerous articles in international peer-reviewed journals and book chapters. She wrote a chapter on the gene she identifies for “Osteogenesis Imperfecta” book, which was printed for the first time in 2013. Prof. Dr. Yasemin Alanay continues her work at Acıbadem Healthcare Group and she has been the dean of Acıbadem University School of Medicine since 2015. Her research interests include pediatric genetic diseases, skeletal dysplasia and societal impacts of genetic diseases.
In this research on Turkish scientists in medical sciences, writers used the largest abstract and reference database of research literature and high quality website, Scopus.
We congratulate our faculty, and wish for their continuing success.
Click here for details of the research.